More in Health+Benefits

Who Benefits from Drug Price Negotiations?
Health+Benefits Who Benefits from Drug Price Negotiations?
Q&A with Shawn Gremminger, President and CEO, National Alliance of Healthcare Pu...
Health+Benefits A New Era of Network Optimization
Price transparency data can help point employers toward health plans that excel ...
Can ICHRAs Bridge the Healthcare Political Divide?
Health+Benefits Can ICHRAs Bridge the Healthcare Political Divide?
Democratic and Republican administrations have wrestled over the terms of the Af...
Youth in Crisis
Health+Benefits Youth in Crisis
Additional specialists and resources are needed to help young people who are str...
A Holistic Approach to Weight Loss and Illness
Health+Benefits A Holistic Approach to Weight Loss and Illness
Q&A with Dr. Ryan Kane, Internal Medicine Fellow and Medical...
U.S. Healthcare System Failing New Mothers
Health+Benefits U.S. Healthcare System Failing New Mothers
Q&A with Munira Gunja, Senior Researcher, Commonwealth Fund ...
The COVID-19 pandemic demonstrated that medical providers continue to misuse antibiotics, exacerbating the long-recognized health threat posed by antimicrobial resistance, according to the head of Swiss Re’s Life & Health Reinsurance division.
Health+Benefits Action Needed to Curb Antimicrobial Resistance, Reinsurance CEO Says